Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Patients' groups, progressives square off over Medicare Alzheimer's decision - Roll Call

Competing campaigns look to influence the debate over dramatically restricting coverage of a controversial treatment drug Aduhelm.

Roll Call

Senate confirms Califf to become Biden's FDA commissioner - Roll Call

Six Republicans voted Tuesday to confirm FDA nominee Robert Califf, who had seen opposition from pockets of the Democratic caucus.

Roll Call

FDA Slams Brakes On Legend Biotech's CAR-T Therapy Trial In Lymphoma Patients

The FDA has instituted a clinical hold on Legend Biotech Corporation's (NASDAQ:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Jury finds New York Times did not defame Sarah Palin – as it happened

Former Republican vice-presidential nominee sued the newspaper in 2017 claiming an editorial damaged her career

The Guardian - US

The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

After the FDA issued warnings about antidepressants, youth suicides rose and mental health care dropped

Depression in young people is vastly undertreated. About two-thirds of depressed youth don’t receive any mental health care at all. Of those who do, a significant proportion rely on antidepressant medications.

The Conversation

Larimar Stock Plunges As FDA Asks For Additional Data To Resolve Clinical Hold On Friedreich's Ataxia Program

Larimar Therapeutics Inc (NASDAQ: LRMR) has rec

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Medical goods among B30m of fake products seized at warehouse

Consumer protection police and Food and Drug Administration (FDA) officials seized a large quantity of falsely labelled, sub-standard products worth about 30 million baht at a warehouse in Khlong Luang district, Pathum Thani province.

Bangkok Post

Commentary: What we can learn about cancer drug development from the COVID-19 approach

As an oncologist, I recognize the arduous path to make a new drug. It is a hard trek that lies between the bench and the patient’s bedside. Ordinarily, it takes five or more years just to get a new drug into the clinic for testing. Similar time is needed for…

Tribune News Service

Weed'n Whiskey: Why Tilray Thinks There Is Gold In Cannabis-Infused Whiskey

This article was originally published on Cannabis.net and appears here with permission.

Benzinga

Senate sets up Califf confirmation vote with narrow procedural win - Roll Call

The nominee to lead the FDA, Robert Califf, survived a Senate procedural vote Monday with the help of five Republicans.

Roll Call

Why Pfizer Shares Are Trading Lower Today

Pfizer Inc (NYSE: PFE) is trading lower Monday after the U.S. Food and Drug Administration (FDA) requested additional data before approving its COVID-19 vaccine for children aged six months to four years old.

Benzinga

Why BioNTech Shares Are Falling Today

BioNTech SE (NASDAQ: BNTX) is trading lower Monday morning after the U.S. Food and Drug Administration (FDA) requested additional data before approving its COVID-19 vaccine for children aged six months to four years old.

Benzinga

FDA Clears Cidara Therapeutics' Phase 1 Trial For Immunotherapeutic Antiviral For Influenza

The

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Denali Receives Formal Letter Regarding FDA Hold On Alzheimer's Potential Program

As previously announced, Denali Therapeutics Inc (NASDAQ: DNLI) was informed via e-mail communication from the FDA that DNL919 (ATV:TREM2) Investigational New Drug (IND) application was placed on clinical hold.

McClatchy Washington Bureau

New monoclonal antibody drug for COVID-19 authorized, FDA says. It works against omicron

A new monoclonal antibody drug has proved to be effective against the coronavirus omicron variant and omicron subvariant, according to the Food and Drug Administration.

Axios

Experts praise Pfizer's delay on kids' vaccines

Experts say waiting for data on three doses is the right call.

Salon

Covid vaccine for young kids delayed

The FDA says it needs more time to review data on a potential three-dose vaccine for children aged 6 months to four

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

FDA AdComm Votes Against Lilly's Lung Cancer Drug, Sintilimab

The FDA advisory committee voted against the full approval of Eli Lilly And Co's (NYSE: LLY) lung cancer treatment over concerns that the clinical trial was conducted only in China and that its results did not apply to U.S. patients.

Tribune News Service

FDA postpones meeting on Pfizer COVID shot for kids under 5

U.S. health officials postponed a meeting of advisers on Pfizer Inc.’s COVID-19 vaccine for children under age 5, after the drugmaker said it has new data to add to its application for clearance.

The Independent UK

Delay ahead for Pfizer's COVID-19 vaccine for kids under 5

U.S. regulators have put the brakes on their push to speed Pfizer’s COVID-19 to children under 5

The Independent UK

Covid shots for children under five pushed back by Pfizer

Company says it will now not have data on third dose protection until April

Axios

Pfizer postpones FDA request for COVID vaccine for kids under 5

The companies said they will wait for more data on three doses for children under 5.

Roll Call

FDA seeks more data before reviewing COVID-19 vaccine for toddlers

The FDA postponed a Feb. 15 review of the Pfizer shots for young children ages 6 months to 4 years old, citing the need for more time.

Benzinga

Why Are Senseonics Shares Falling Despite FDA OK For Next-Gen Eversense CGM

The FDA has approved Senseonics Holdings Inc's (NYSE:

1 … 238 239 240 241

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.